Literature DB >> 11246277

Hepatitis C virus seroprevalence and risk factors among patients with HIV infection.

M C Mendes-Corrêa1, A A Barone, C Guastini.   

Abstract

The objective of this study was to evaluate the prevalence and risk factors associated with HCV infection in a group of HIV seropositive patients. We analyzed the medical records of 1,457 patients. All patients were tested for HCV infection by third generation ELISA. Whenever possible, a sample of the positive patients was also tested for HCV by PCR. HCV positive patients were analyzed according to their risk factors for both infections. The prevalence of anti-HCV positive patients was 17.7% (258 patients). Eighty-two (82) of these patients were also tested by PCR and 81 were positive for HCV virus (98%). One hundred fifty-one (58.5%) were intravenous drug users (IDU); 42 (16.3%) were sexual partners of HIV patients; 23 (8.9%) were homosexual males; 12 (4.7%) had received blood transfusion; 61 (17.5%) had promiscuous sexual habits; 14 (5.4%) denied any risk factor; 12 (4.7%) were sexual partners of IDU. Two hundred four patients mentioned only one risk factor. Among them, 28 (10.9%) were sexual partners of HIV-positive patients. Although intravenous drug use was the most important risk factor for co-infection, sexual transmission seemed to contribute to the high HCV seroprevalence in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246277     DOI: 10.1590/s0036-46652001000100003

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  9 in total

1.  Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.

Authors:  Fernando H Wolff; Sandra C Fuchs; Nêmora N T Barcellos; Paulo Ricardo de Alencastro; Maria Letícia R Ikeda; Ajácio B M Brandão; Maicon Falavigna; Flávio D Fuchs
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

2.  Factors associated with seroprevalence of hepatitis C among dentists at a large Brazilian city.

Authors:  Vera Lúcia S Resende; Mauro Henrique G Abreu; Saul M Paiva; Rosângela Teixeira; Isabela A Pordeus
Journal:  Virol J       Date:  2009-12-23       Impact factor: 4.099

3.  Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China.

Authors:  Yu-Hua Ruan; Kun-Xue Hong; Shi-Zhu Liu; Yi-Xin He; Feng Zhou; Guan-Ming Qin; Kang-Lin Chen; Hui Xing; Jian-Ping Chen; Yi-Ming Shao
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

Review 4.  Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.

Authors:  Fatima Mitiko Tengan; Karim Yakub Ibrahim; Bianca Peixoto Dantas; Caroline Manchiero; Mariana Cavalheiro Magri; Wanderley Marques Bernardo
Journal:  BMC Infect Dis       Date:  2016-11-09       Impact factor: 3.090

5.  Alcohol misuse and illicit drug use are associated with HCV/HIV co-infection.

Authors:  D Simon; R T Michita; J U Béria; D C Tietzmann; A T Stein; V R Lunge
Journal:  Epidemiol Infect       Date:  2014-02-04       Impact factor: 4.434

6.  Hepatitis C Virus Infection in HIV Positive Attendees of Shiraz Behavioral Diseases Consultation Center in Southern Iran.

Authors:  Mohammad Ali Davarpanah; Farnaz Khademolhosseini; Abdolreza Rajaeefard; Alireza Tavassoli; Seyed Kamalaldin Yazdanfar; Abbas Rezaianzadeh
Journal:  Indian J Community Med       Date:  2013-04

7.  Phylogenetic analysis of the emergence of main hepatitis C virus subtypes in São Paulo, Brazil.

Authors:  Anna Shoko Nishiya; César de Almeida-Neto; Camila Malta Romano; Cecília Salete Alencar; Suzete Cleusa Ferreira; Claudia Di-Lorenzo-Oliveira; José Eduardo Levi; Nanci Alves Salles; Alfredo Mendrone-Junior; Ester Cerdeira Sabino
Journal:  Braz J Infect Dis       Date:  2015-08-19       Impact factor: 3.257

Review 8.  Prevalence of human immunodeficiency virus/hepatitis C virus co-infection in Brazil and associated factors: a review.

Authors:  Valdete Meurer Kuehlkamp; Fabiana Schuelter-Trevisol
Journal:  Braz J Infect Dis       Date:  2013-05-13       Impact factor: 3.257

9.  Human immunodeficiency virus and hepatitis C virus/hepatitis B virus co-infection in Southern Brazil: clinical and epidemiological evaluation.

Authors:  Sonia Mara Raboni; Felipe Francisco Tuon; Nayara Carvalho Polido Beloto; Henrique Demeneck; Andre Oliveira; Denis Largura; Andressa Gervasoni Sagrado; Bárbara Perdonsini Lima; João Paulo Franzoni; Maria Lucia Pedroso
Journal:  Braz J Infect Dis       Date:  2014-07-11       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.